SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Kopran informs about issue of securities

03 Dec 2021 Evaluate

Kopran has informed that meeting of the Board of Directors of the Company is scheduled to be held on Wednesday, 8th December, 2021 at the Registered Office, to consider issue of Equity Shares on Preferential basis to Promoter, Promoter Group and Others as may be permitted under applicable laws, subject to such regulatory/statutory approvals as may be required, including the approval of the shareholders of the Company. Further, pursuant to the Company's Code of Conduct for Regulating & Reporting of Trading by Insiders and for Fair Disclosure, the 'Trading Window' for dealing in the securities of the Company shall be closed from 3rd December, 2021, will re-open 48 hours after the declaration of the outcome of the Board Meeting. 

The above information is a part of company’s filings submitted to BSE.


Kopran Share Price

159.60 4.70 (3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1675.20
Dr. Reddys Lab 1235.40
Cipla 1238.30
Zydus Lifesciences 942.55
Lupin 2324.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×